N@N

Cyberonics To Present At The 31st Annual J.P. Morgan Healthcare Conference

_{//health-fitness.news-articles.net/content/2012/ .. 1st-annual-j-p-morgan-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, December 19th 2012 at 6:16 GMT by Market Wire}  

Cyberonics To Present At The 31st Annual J.P. Morgan Healthcare Conference -- HOUSTON, Dec. 19, 2012 /PRNewswire/ --

HOUSTON, Dec. 19, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: [ CYBX ]), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 31^st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013, in San Francisco.

Dan Moore , Cyberonics' President and Chief Executive Officer, will speak at 10:00 AM Pacific Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at [ http://www.cyberonics.com ] on January 9, 2013. 

About Cyberonics, Inc. and the VNS Therapy^® System

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at [ www.cyberonics.com ].

Contact Information

Greg Browne , CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main:  (281) 228-7262
Fax:  (281) 218-9332
[ ir@cyberonics.com ]

SOURCE Cyberonics, Inc.